Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.schres.2018.02.050
PubMed Identifier: 29519756
Publication URI: http://europepmc.org/abstract/MED/29519756
Type: Journal Article/Review
Volume: 199
Parent Publication: Schizophrenia research
ISSN: 0920-9964